Skip to main content
Louisiana Society of Health-System Pharmacists
Board of Directors
Antimicrobial Stewardship Committee
How to Whitelist Emails
Share this page
Share on Facebook
Share on Twitter
Share on LinkedIn
SCLSHP Gentamicin: The Good, Bad and Ugly
TYPE OF ACTIVITY/WHO SHOULD ATTEND:
-based activity is of importance to all pharmacists.
At the conclusion of this activity, pharmacists should be able to:
Analyze the appropriateness of gentamicin treatment in a patient
Describe the need for patient informed consent regarding gentamicin-induced toxicity.
Identify patients for clinical development of gentamicin induced nephrotoxicity and ototoxicity
Gary McGarity, PharmD
There are no fees for attendance at the meeting for LSHP members. For non-LSHP members, there will be a $10 fee for continuing education credit.
To Alexis Horace at 225-219-9660
SPONSORED BY: This activity is sponsored by the South Central Louisiana Society of Health-System Pharmacists.
8/22/2017 6:30 PM
ULM School of Pharmacy Baton Rouge